Journal article
Parvalbumin gene transfer impairs skeletal muscle contractility in old mice
KT Murphy, DJ Ham, JE Church, T Naim, J Trieu, DA Williams, GS Lynch
Human Gene Therapy | MARY ANN LIEBERT, INC | Published : 2012
DOI: 10.1089/hum.2011.210
Abstract
Sarcopenia is the progressive age-related loss of skeletal muscle mass associated with functional impairments that reduce mobility and quality of life. Overt muscle wasting with sarcopenia is usually preceded by a slowing of the rate of relaxation and a reduction in maximum force production. Parvalbumin (PV) is a cytosolic Ca2+ buffer thought to facilitate relaxation in muscle. We tested the hypothesis that restoration of PV levels in muscles of old mice would increase the magnitude and hasten relaxation of submaximal and maximal force responses. The tibialis anterior (TA) muscles of young (6 month), adult (13 month), and old (26 month) C57BL/6 mice received electroporation- assisted gene tr..
View full abstractRelated Projects (2)
Grants
Awarded by Australian Research Council
Funding Acknowledgements
This study was supported by research grants from the Australian Research Council Discovery-Project funding scheme (DP0665071, DP0772781) and The University of Melbourne Early Career Researcher scheme. The support of the Rebecca L. Cooper Medical Research Foundation is also gratefully acknowledged. K.T. Murphy holds a Career Development Fellowship from the National Health and Medical Research Council (NHMRC).